Hendrikx, 2006 trial summary    PDF trial summary

A randomised clinical trial investigating the effect of Bone marrow mononuclear cells versus control in patients with a postinfarction nonviable scar

        Z

Circulation 2006;114:I101-7  



Studied treatment intramyocardial injection of autologous mononuclear bone marrow cells during coronary artery bypass graft
Control treatment



Patients patients with a postinfarction nonviable scar
Group sizes-9 / -9



Blindness Inclusion period
Follow-up duration 4 months Centers
Lost to FU geographical localisation
Primary endpoint Design



EndpointX1N1X0N0TE95% CI NYHA deterioration - -9 - -9 no data LVEF - -9 - -9 no data Peak VO2 (mL/kg/min) - -9 - -9 no data acute heart failure - -9 - -9 no data cardiac event - -9 - -9 no data NYHA class - -9 - -9 no data LV End-Systolic Volume - -9 - -9 no data Minnesota Living With Heart Failure Questionnaire - -9 - -9 no data ventricular tachycardia - -9 - -9 no data 6-min Walk, m - -9 - -9 no data NT-proBNP - -9 - -9 no data all-cause mortality - -9 - -9 no data0,22,01,0

Hendrikx M, Hensen K, Clijsters C, Jongen H, Koninckx R, Bijnens E, Ingels M, Jacobs A, Geukens R, Dendale P, Vijgen J, Dilling D, Steels P, Mees U, Rummens JL Recovery of regional but not global contractile function by the direct intramyocardial autologous bone marrow transplantation: results from a randomized controlled clinical trial. Circulation 2006;114:I101-7     [PMID: 16820557]   link to pdf   add to Mendeley  



Registering number (see trial on clinicaltrials.gov)
Code Name